<p><b>Background</b>: Approximately 50% of survivors of childhood acute lymphoblastic leukemia (ALL) demonstrate cognitive impairments. However, the trajectory of change and contributing neuropathology is unclear, limiting our ability to tailor intervention content and timing. This study aimed to explore information processing abilities and brain morphology early post-treatment for pediatric ALL.</p> <p><b>Procedure</b>: Twenty-one children at the end of ALL treatment and 18 controls underwent neuropsychological assessment. A subset also completed structural magnetic resonance imaging.</p> <p><b>Results</b>: A principal component analysis generated two cognitive factors: information processing capacity and information processing speed. Comp...
OBJECTIVE: To determine whether prophylactic CNS chemotherapy for childhood acute lymphoblastic leuk...
Objective There is growing evidence of cerebellar-frontal system change in children treated for leuk...
Aim: To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leu...
© 2017 Dr. Simone HearpsBackground: Paediatric acute lymphoblastic leukaemia (ALL) treated with chem...
Cognitive late-effects have been identified in patients treated with chemotherapy-only protocols for...
OBJECTIVE: Using multidisciplinary treatment modalities the majority of children with cancer can be ...
Survival rates for children with acute lymphoblastic leukemia (ALL) approach 95%. At the same time, ...
Using multidisciplinary treatment modalities the majority of children with cancer can be cured but w...
Acute Lymphocytic Leukemia (ALL) is the most prevalent form of cancer diagnosed in children. The cu...
BACKGROUND: Central nervous system (CNS) directed chemotherapy is replacing prophylactic cranial irr...
OBJECTIVES: To investigate persistent neuropsychologic late effects in children treated for acute ly...
Objectives: To investigate persistent neuropsychologic late effects in children treated for acute ly...
Acute lymphoblastic leukaemia (ALL) is the most common form of malignancy in children. With current ...
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Pediatric acute lymphoblasti...
Objective There is growing evidence of cerebellar-frontal system change in children treated for leuk...
OBJECTIVE: To determine whether prophylactic CNS chemotherapy for childhood acute lymphoblastic leuk...
Objective There is growing evidence of cerebellar-frontal system change in children treated for leuk...
Aim: To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leu...
© 2017 Dr. Simone HearpsBackground: Paediatric acute lymphoblastic leukaemia (ALL) treated with chem...
Cognitive late-effects have been identified in patients treated with chemotherapy-only protocols for...
OBJECTIVE: Using multidisciplinary treatment modalities the majority of children with cancer can be ...
Survival rates for children with acute lymphoblastic leukemia (ALL) approach 95%. At the same time, ...
Using multidisciplinary treatment modalities the majority of children with cancer can be cured but w...
Acute Lymphocytic Leukemia (ALL) is the most prevalent form of cancer diagnosed in children. The cu...
BACKGROUND: Central nervous system (CNS) directed chemotherapy is replacing prophylactic cranial irr...
OBJECTIVES: To investigate persistent neuropsychologic late effects in children treated for acute ly...
Objectives: To investigate persistent neuropsychologic late effects in children treated for acute ly...
Acute lymphoblastic leukaemia (ALL) is the most common form of malignancy in children. With current ...
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Pediatric acute lymphoblasti...
Objective There is growing evidence of cerebellar-frontal system change in children treated for leuk...
OBJECTIVE: To determine whether prophylactic CNS chemotherapy for childhood acute lymphoblastic leuk...
Objective There is growing evidence of cerebellar-frontal system change in children treated for leuk...
Aim: To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leu...